Your browser doesn't support javascript.
loading
circEZH2E2 /E3 is a dual suppressor of miR363/miR708 to promote EZH2 expression and prostate cancer progression.
Su, Zhengzheng; Zhang, Mengni; Luo, Han; Zhong, Jinjing; Tan, Junya; Xu, Yunyi; Pan, Xiuyi; Zeng, Hao; Nie, Ling; Xu, Miao; Chen, Ni; Chen, Xueqin; Zhou, Qiao.
Afiliação
  • Su Z; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Zhang M; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Luo H; Department of Thyroid and Parathyroid Surgery, West China Hospital of Sichuan University, Chengdu, China.
  • Zhong J; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Tan J; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Xu Y; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Pan X; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Zeng H; Department of Urology, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Nie L; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Xu M; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Chen N; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Chen X; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
  • Zhou Q; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China.
Cancer Sci ; 114(4): 1378-1395, 2023 Apr.
Article em En | MEDLINE | ID: mdl-36519785
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China